These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21849807

  • 1. Elevated tumor necrosis factor in serum is associated with increased retinal ischemia in proliferative eales' disease.
    Saxena S, Khanna VK, Pant AB, Meyer CH, Singh VK.
    Pathobiology; 2011; 78(5):261-5. PubMed ID: 21849807
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1 and tumor necrosis factor-alpha: novel targets for immunotherapy in Eales disease.
    Saxena S, Pant AB, Khanna VK, Agarwal AK, Singh K, Kumar D, Singh VK.
    Ocul Immunol Inflamm; 2009; 17(3):201-6. PubMed ID: 19585364
    [Abstract] [Full Text] [Related]

  • 3. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: role of inflammation-mediated angiogenesis in the pathogenesis of Eales disease.
    Sen A, Paine SK, Chowdhury IH, Mukherjee A, Choudhury S, Mandal LK, Bhattacharya B.
    Retina; 2011; 31(7):1412-20. PubMed ID: 21394064
    [Abstract] [Full Text] [Related]

  • 4. Eales' disease: diagnosis and management.
    Das T, Pathengay A, Hussain N, Biswas J.
    Eye (Lond); 2010 Mar; 24(3):472-82. PubMed ID: 20075970
    [Abstract] [Full Text] [Related]

  • 5. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease.
    Srivastava P, Saxena S, Khanna VK, Kumar D, Nath R, Seth PK.
    Indian J Ophthalmol; 2000 Dec; 48(4):307-9. PubMed ID: 11340890
    [Abstract] [Full Text] [Related]

  • 6. [TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
    Spranger J, Meyer-Schwickerath R, Klein M, Schatz H, Pfeiffer A.
    Med Klin (Munich); 1995 Mar 01; 90(3):134-7. PubMed ID: 7723714
    [Abstract] [Full Text] [Related]

  • 7. Visualization of retinal vasculitis in Eales' disease.
    Atmaca LS, Idil A, Gündüz K.
    Ocul Immunol Inflamm; 1993 Mar 01; 1(1-2):41-8. PubMed ID: 22827191
    [Abstract] [Full Text] [Related]

  • 8. Determination of carbonyl group content in plasma proteins as a useful marker to assess impairment in antioxidant defense in patients with Eales' disease.
    Rajesh M, Sulochana KN, Coral K, Punitham R, Biswas J, Babu K, Ramakrishnan S.
    Indian J Ophthalmol; 2004 Jun 01; 52(2):139-44. PubMed ID: 15283219
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series.
    Ishaq M, Feroze AH, Shahid M, Baig MA, Ameen SS, Feroze SH, Chishti RA.
    Eye (Lond); 2007 Nov 01; 21(11):1403-5. PubMed ID: 16980931
    [Abstract] [Full Text] [Related]

  • 10. Treatment of Eales' disease with scatter laser photocoagulation.
    Magargal LE, Walsh AW, Magargal HO, Robb-Doyle E.
    Ann Ophthalmol; 1989 Aug 01; 21(8):300-2. PubMed ID: 2478067
    [Abstract] [Full Text] [Related]

  • 11. Decreased platelet membrane fluidity in retinal periphlebitis in Eales' disease.
    Saxena S, Srivastava P, Kumar D, Khanna VK, Seth PK.
    Ocul Immunol Inflamm; 2006 Apr 01; 14(2):113-6. PubMed ID: 16597541
    [Abstract] [Full Text] [Related]

  • 12. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease.
    Perentes Y, Chan CC, Bovey E, Uffer S, Herbort CP.
    Klin Monbl Augenheilkd; 2002 Apr 01; 219(4):311-4. PubMed ID: 12022026
    [Abstract] [Full Text] [Related]

  • 13. Increased homocysteine, homocysteine-thiolactone, protein homocysteinylation and oxidative stress in the circulation of patients with Eales' disease.
    Bharathselvi M, Biswas J, Selvi R, Coral K, Narayanasamy A, Ramakrishnan S, Sulochana KN.
    Ann Clin Biochem; 2013 Jul 01; 50(Pt 4):330-8. PubMed ID: 23761385
    [Abstract] [Full Text] [Related]

  • 14. Association of Mycobacterium tuberculosis in the causation of Eales' disease: an institutional experience.
    Rajpal, Singh UB, Mohapatra S, Wagh VK, Porwal C, Kaushik A.
    Indian J Med Microbiol; 2015 Feb 01; 33 Suppl():43-5. PubMed ID: 25657155
    [Abstract] [Full Text] [Related]

  • 15. [Eales' disease].
    Errera MH, Pratas A, Goldschmidt P, Sedira N, Sahel JA, Benesty J.
    J Fr Ophtalmol; 2016 May 01; 39(5):474-82. PubMed ID: 27185661
    [Abstract] [Full Text] [Related]

  • 16. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P, Shukla D, Rajendran A, Kim R, Namperumalsamy P, Muthukkaruppan V.
    Retina; 2008 Jun 01; 28(6):817-24. PubMed ID: 18536597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of mycobacteria with Eales' disease.
    Therese KL, Deepa P, Therese J, Bagyalakshmi R, Biswas J, Madhavan HN.
    Indian J Med Res; 2007 Jul 01; 126(1):56-62. PubMed ID: 17890825
    [Abstract] [Full Text] [Related]

  • 19. Total antioxidant capacity in Eales' disease, uveitis & cataract.
    Selvi R, Angayarkanni N, Biswas J, Ramakrishnan S.
    Indian J Med Res; 2011 Jul 01; 134(1):83-90. PubMed ID: 21808139
    [Abstract] [Full Text] [Related]

  • 20. [Changes of serum soluble P-selectin and tumor necrotic factor-alpha in patients with CMV induced acute coronary syndrome].
    Wang XM, Li Y, Huang C, Zhang RH, Guo HT, Chen H, Wang HC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun 01; 19(2):149-51. PubMed ID: 16027783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.